AngioDynamics (ANGO) Reports In-Line Q4 EPS ; Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.44 +0.46%
Revenue Growth %: +6.3%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.3%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $91.1 million versus the consensus estimate of $90.74 million.
GUIDANCE:
AngioDynamics sees FY2024 EPS of $0.28-$0.34, versus the consensus of ($0.08). AngioDynamics sees FY2024 revenue of $328-333 million, versus the consensus of $323 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
